Delivery Order SPE2DB20D1100-SPE2DB25FE4K8
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,650.39 to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Provocholine inhalation solution in 18 mL packs. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA and is scheduled for completion by August 28, 2025. The product will be delivered to the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $1,100.26 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Provocholine Inhalation Solution in an 18ML pack. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of September 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a single transaction under the company's broader...
- The Defense Logistics Agency awarded a $2,200.52 delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs under a firm fixed price contract. The award was made on September 5, 2025, with an ultimate completion date of September 8, 2025. This is a non-set-aside competitive award, with performance to be completed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract issued under the company's...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Provocholine inhalation solution in 18 mL packages. The $4,426.65 delivery order has a completion date of March 7, 2024 and was awarded on March 6, 2024. Amerisourcebergen Drug Corp is a prime contractor for DLA Troop Support Medical, providing a wide range of pharmaceutical products and medical supplies to Department of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Provocholine Inhalation Solution in 18ML packs, with a contract ceiling value of $11,511.90. This firm fixed-price delivery order, which is not set-aside, represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,670.65 order is for the provision of Provocholine Inhalation Solution, Pack 18ML, a pharmaceutical product. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $7,538.38 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on September 17, 2025, for Provocholine inhalation solution in 18-milliliter packs. The contract is set to be completed by September 18, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. This delivery order...
- The Defense Logistics Agency awarded a $5,501.30 delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order is a child delivery order issued under AmerisourceBergen's larger indefinite delivery contract with...
- The Defense Logistics Agency awarded a delivery order valued at $16,503.90 to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs. This delivery order, issued on July 19, 2025, with an ultimate completion date of July 21, 2025, operates under a firm fixed price structure with no set-aside designation. The award represents a competitive procurement action through the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $2,136.52 firm fixed-price contract is for the supply of 4565334260 - Provocholine Inhalation Solution Packs (18mL). The contract has an ultimate completion date of August 5, 2024 and was awarded on August 2, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE4K8Delivery Order
The Defense Logistics Agency (DLA) awarded a $2,200.52 delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML pack quantities. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of September 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's larger relationship with DLA for pharmaceutical and medical supply provision. This award is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen serves as a critical pharmaceutical distributor for federal medical procurement, supplying a comprehensive range of medications, vaccines, and medical devices to support military and veteran healthcare systems. The company's role as a primary vendor within DLA's pharmaceutical supply chain reflects its established capability to fulfill federal medical requirements through competitive procurement processes, with delivery orders spanning therapeutic domains from specialty medications to diagnostic supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/3/25 |